发明名称 |
Compositions and methods for silencing SMAD4 |
摘要 |
The present invention provides compositions comprising therapeutic nucleic acids such as interfering RNA (e.g., dsRNA such as siRNA) that target SMAD4 gene expression, lipid particles comprising one or more (e.g., a cocktail) of the therapeutic nucleic acids, methods of making the lipid particles, and methods of delivering and/or administering the lipid particles (e.g., for treating anemia of inflammation in humans). |
申请公布号 |
US9035039(B2) |
申请公布日期 |
2015.05.19 |
申请号 |
US201213725796 |
申请日期 |
2012.12.21 |
申请人 |
Protiva Biotherapeutics, Inc. |
发明人 |
Dhillon Ammen P.;Lee Amy C. H.;MacLachlan Ian |
分类号 |
C07H21/04;C07H21/02;A61K31/7105;A61K31/713 |
主分类号 |
C07H21/04 |
代理机构 |
Viksnins Harris & Padys PLLP |
代理人 |
Viksnins Harris & Padys PLLP |
主权项 |
1. A composition comprising an interfering RNA that silences SMAD4 gene expression, wherein the interfering RNA is an siRNA that comprises a sense strand and a complementary antisense strand, wherein the siRNA is Identifier 3 (SEQ ID NO:7 and SEQ ID NO:8). |
地址 |
Burnaby, BC CA |